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have mainly analyzed short-term efficacy of the outcome
after a specific intervention or for a specific degree of
ischemia in terms of quality of life.3,4 Cook et al3 found sig-
nificant improvements in symptoms and in general health 6
weeks after angioplasty for intermittent claudication,
whereas Gibbons et al4 found that better functioning or
less severe symptoms in limb-threatening ischemia before
treatment were associated with improved functioning 6
months after surgery. These measures have mostly analyzed
the outcome after a successful revascularization. Few stud-
ies have analyzed the patients’ quality of life after an unsuc-
cessful revascularization. From the patient’s perspective, it
is also important to know what the quality of life will be
like if the revascularization fails. In clinical practice, a mea-
suring of functional health status outcome may provide
valuable information about these patients’ quality of life,
and it may have implications for their clinical treatment.
High rates of comorbidity, especially coronary artery
disease, cerebrovascular disease, and diabetes mellitus,5,6
are common, and this probably influences the patients’
quality of life in addition to the lower limb ischemia. In
one study, almost 10% of patients with lower limb
ischemic disease had cerebrovascular disease, and 28% of
the patients had coronary heart disease.5 Furthermore,
patients with diabetes mellitus have a sevenfold higher risk
of lower limb amputation than people without diabetes
mellitus.7 Finally, the natural history of lower limb disease
has shown symptom progress in about 16% of those with
intermittent claudication. A full 25% of patients will
require surgery or gangrene will develop, and less than 4%
of patients require a major amputation,8 a fact that might
also influence the outcome.
The primary goals of surgical treatment and care in
patients with lower limb ischemia are the elimination of
ischemic symptoms and the addition of quality of life to
survival, which calls for a broader measuring of the out-
come. In recent years, there has been an increasing inter-
est in applying to aggressive surgical revascularization
through bypass grafting or angioplasty. Traditionally, the
outcomes of these procedures have been based on surgical
benefits for limb salvage and patency rates. Patency rates
have been reported to be more than 80% the year after
bypass grafting, with a slow decline to 60% at 4 years.
However, angioplasty had somewhat lower patency rates
of 50% to 60% at 1 year.1 The efficacy of surgical revascu-
larization to provide a limb salvage rate of 76% 12 months
after either surgery or percutaneous transluminal angio-
plasty (PTA) has also been reported.2 The outcome of
these surgical benefits, however, also requires information
about the benefits for patients’ quality of life.
Quality of life analysis has become increasingly impor-
tant as an outcome measure in vascular surgery. Studies
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Purpose: The impact of hemodynamically successful or unsuccessful bypass grafting or angioplasty on patients’ quality
of life was assessed throughout the first year postsurgery.
Methods: A total of 146 patients, 97 patients who underwent successful revascularization and 49 patients who under-
went unsuccessful revascularization, were assessed for quality of life with the Nottingham Health Profile.
Results: Hemodynamically successful revascularization resulted in an immediate and lasting impact on the patients’
quality of life. Despite hemodynamic failure, patients had improvements in pain, emotional reactions, sleep, and fam-
ily relationships at the 1-year follow-up assessment. A successful revascularization in patients with claudication demon-
strated the most marked quality of life benefits, including all health dimensions that were not normal at baseline.
Patients with critical ischemia had improved quality of life for pain, sleep, and physical mobility. High ankle pressure,
in the claudicant group, and a high sense of coherence were significantly associated with high quality of life.
Conclusion: The treatment of lower limb ischemia resulted in an immediate and relatively lasting improvement in
patients’ quality of life. Patients who underwent hemodynamically successful bypass grafting procedures or angioplasty
demonstrated higher quality of life benefits than patients who underwent a failed bypass grafting procedure. Quality
of life was further determined by means of the patients’ sense of coherence. (J Vasc Surg 2001;33:114-22.)
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In addition to the identification of risk factors and the
natural history of the disease, it is important to take the
patients’ own resources into consideration when analyzing
the patients’ perception of the success. Antonovsky9
defines sense of coherence as a global orientation that
expresses the extent to which one has a pervasive, endur-
ing though dynamic feeling of confidence that the stimuli
deriving from one’s internal and external environments in
the course of living are structured, predictable, and explic-
able. From the clinical point of view, patients with a weak
sense of coherence may need more close supportive and
complementary care then patients with a strong sense of
coherence. Thus, the information on sense of coherence is
also useful knowledge when analyzing the benefits of vas-
cular surgery for patients’ quality of life.
The aim of this study was to assess the impact of
hemodynamically successful or unsuccessful bypass graft-
ing procedures or angioplasty on patients’ quality of life
throughout the first year and to identify which patients
derive the most benefit from revascularization.
MATERIALS AND METHODS
Patients. This was a multicenter study that included
patients consecutively referred for intervention at the vas-
cular surgical units during 14 months in three counties in
southern Sweden.10 A total of 168 patients with varying
degrees of ischemia were assessed at baseline and at 6 and
12 months after revascularization. The entry criteria
included patients admitted for active treatment, who had
no communication difficulties, or no other treated disease
in the system of the lower limbs that restricted their walk-
ing capacity. Of 154 patients, 146 patients (95%) partici-
pated at the 12-month follow-up. Eight patients dropped
out of the study; 5 patients died at 6 months, 5 patients
died at 12 months, and 3 patients did not wish to partici-
pate. The severity of ischemia was graded according to
suggested standards for grading lower limb ischemia.11
For the definition of hemodynamic success, the recommen-
dation of an increase of ankle-brachial pressure index
(ABPI) by 0.15 has been chosen as the minimum require-
ment for clinically significant change.12 Thus, the criterion
for successful revascularization applied in this study was
that the ABPI increased by 0.15 or more at 6 months and
remained the same or was better at 12 months. Also con-
sidered successful were patients who had an ABPI change
of less than 0.15 at 6 months, but who reached a change
Table I. Patient risk factors at baseline (n = 146)
Patients with claudication Patients with critical ischemia*
Successful Unsuccessful Successful† Unsuccessful†
(n = 55) (n = 29) P value‡ (n = 42) (n = 20) P value‡
Risk factors* (%)
Smoking 32 (58.2) 12 (41.4) NS 12 (28.6) 5 (25) NS
Stroke/TIA 3 (5.5) 3 (10.3) NS 2 (4.8) 3 (15) NS
Diabetes mellitus 4 (7.3) 6 (20.7) NS 8 (19) 12 (60) < .001
Hyperlipemia 12 (21.8) 1 (3.4) .02 1 (2.4) 2 (10) NS
Hypertension 16 (29.1) 12 (41.4) NS 20 (47.6) 10 (50) NS
Heart disease 16 (29.1) 12 (41.4) NS 17 (40.5) 10 (50) NS
Chronic lung disease 4 (7.3) 4 (13.8) NS — — —
Kidney disease — 2 (6.9) .04 4 (9.5) 1 (5) NS
*According to Rutherford, 1997.
†According to Carter, 1969.
‡Tested by means of the χ2 test.
NS, Not significant; TIA, transient ischemic attack.
Table II. Demographic characteristic of hemodynami-
cally successful or unsuccessful revascularization in
patients with lower limb ischemia (n = 146)
Successful Unsuccessful P
(n = 97) (n = 49) value*
Age (years), mean (SD) 69 (10) 71 (11) NS
Sex (%) NS
Men 55 (56.7) 30 (61.2)
Women 42 (43.3) 19 (38.8)
Severity of disease (%) NS
Claudication 55 (56.7) 29 (59.2)
Critical ischemia 42 (43.3) 20 (40.8)
Leg side of disease (%) NS
Unilateral 84 (86.6) 41 (83.7)
Bilateral 13 (13.4) 8 (16.3)
Level of disease (%) NS
Iliac 37 (38.1) 15 (30.6)
Femoral (above-knee) 44 (45.4) 20 (40.8)
Below-knee (distal) 16 (16.5) 14 (28.6)
Type of intervention (%) NS
Angioplasty 27 (56.3) 13 (56.5)
Angioplasty/stent 21 (43.8) 10 (43.5)
Surgical revascularization 48 (49.5) 26 (53.1)
Amputation — 8 (16.3)
Secondary revascularization 10 (10.3) 3 (6.1)
Walking ability of patients with < .01
claudication (%)
Reported maximum walking 30 (54.5) 7 (25.9)
distance ≥ 300 m
Reported maximum walking 25 (45.5) 20 (74.1)
distance < 300 m
*Tested by means of the χ2 test.
NS, Not significant.
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of 0.15 or more at 12 months, compared with baseline.
An unsuccessful revascularization was consequently
defined as ABPI changes less than 0.15 both at 6 and 12
months or an increased ABPI at 6 months, but changes
below 0.15 at 12 months, compared with baseline.
Clinical assessment. At baseline, routine medical his-
tory and risk factors were obtained in accordance with the
Swedish Vascular Registry (Swedvasc),13 and clinical
examinations were performed at follow-up after 6 and 12
months. Palpable pulse, ankle-brachial pressure (ABP),
Table III. The NHP median scoring for part I and II of NHP after hemodynamically successful surgical revascularization at
baseline and after 6 and 12 months (n = 97)
ABPI increased by 0.15 or more at 6 and 12 months (n = 87)
Baseline 6 months 12 months P value
Part I, median (q1 to q3)*
Energy 23.8 (0.0-63.2) 0.0 (0.0-23.8) 0.0 (0.0-60.6) .002†‡§
Pain 29.4 (18.5-63.5) 7.6 (0.0-29.4) 7.6 (0.0-30.5) .0001†§
Emotional reactions 7.7 (0.0-24.5) 0.0 (0.0-12.2) 0.0 (0.0.-9.0) .0001†§
Sleep 11.1 (0.0-52.8) 11.1 (0.0-33.1) 0.0 (0.0-33.1) .0001†§
Social isolation 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) NS
Physical mobility 20.3 (10.2-38.1) 10.1 (0.0-20.7) 10.2 (0.0-24.5) .0001†‡§
Part II, n (%)
Paid employment¶ 11 (12.6) 2 (2.3) 4 (46) .006†§
Housework 37 (42.5) 25 (28.7) 25 (28.7) .018§
Family relationships 10 (11.5) 3 (3.4) 2 (2.3) .009§
Social life 32 (36.8) 11 (12.6) 6 (6.9) .0001§
Sex life 20 (23) 21 (24.1) 16 (18.4) NS
Hobbies 43 (49.4) 19 (21.8) 24 (27.6) .0001†§
Holidays 43 (49.4) 19 (21.8) 21 (24.1) .0001†§
*Tested by means of the Friedman test. Median value (25th and 75th percentile). A high score indicates more perceived problems.
†Baseline versus 6 months.
‡Six months versus 1 year.
§Baseline versus 1 year.
 Tested by means of the Cochran test. Number experiencing problem (%).
¶Includes 24 patients.
ABPI, Ankle-brachial pressure index; NS, not significant.
Table IV. The NHP median scoring for part I and II of NHP after hemodynamically unsuccessful surgical revasculari-
zation at baseline, and after 6 and 12 months (n = 49)
ABPI changes less than 0.15 at 6 and 12 months (n = 28)
Baseline 6 months 12 months P value
Part I, median (q1 to q3)*
Energy 23.8 (0.0-55.3) 0.0 (0.0-33.5) 0.0 (0.0-60.6) NS
Pain 41.5 (18.5-69.4) 20.1 (0.0-29.4) 18 (0.0-41.7) .0001†‡
Emotional reactions 7.7 (0.0-19.5) 0.0 (0.0-11.6) 0.0 (0.0-18.2) NS
Sleep 15.4 (0.0-62.1) 11.1 (0.0-33.6) 11.1 (0.0-40.1) NS
Social isolation 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) NS
Physical mobility 20.5 (8-33.4) 20.7 (0.0-46.1) 10.4 (0.0-30.8) NS
Part II, n (%)§
Paid employment 4 (14.3) 2 (7.1) 1 (3.6) NS
Housework 12 (42.9) 9 (32.1) 10 (35.7) NS
Family relationships 4 (14.3) 2 (7.1) 1 (3.6) NS
Social life 11 (39.3) 6 (21.4) 3 (10.7) NS
Sex life 11 (39.3) 8 (28.6) 8 (28.6) NS
Hobbies 13 (46.4) 11 (39.3) 14 (50) NS
Holidays 12 (42.9) 8 (28.6) 10 (35.7) NS
*Tested by means of the Friedman test. Median value (25th and 75th percentile). A high score indicates more perceived problems.
†Baseline versus 6 months.
‡Baseline versus 1 year.
§Tested by means of the Cochran test. Number experiencing problem (%).
 Includes four patients.
ABPI, Ankle-brachial pressure index; NS, not significant.
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and ABPI were reported. Toe systolic pressure measure-
ment was performed on patients with diabetes mellitus.
ABPI was calculated by taking the ABP on the treatment
side and dividing by the highest arm pressure. For patients
with claudication only, a standard treadmill test (3 km/h
with a 14% inclination) was performed at baseline and at
the follow-up intervals as a means of measuring the time
to initial claudication distance and the time to absolute
claudication distance.
Quality of life assessment. The Nottingham Health
Profile (NHP) developed by Hunt et al14 was chosen as a
means of measuring quality of life. The NHP instrument
has two parts. Part I consists of 38 yes/no items that
reflect the patient’s degree of distress within the dimen-
ABPI below 0.15 at 6 months and at 0.15 or greater at 12 months (n = 10)
Baseline 6 months 12 months P value
69.7 (17.8-100) 36.8 (0.0-100) 31.6 (0.0-61.2) NS
72 (42.8-93.5) 41.1 (10.9-72.6) 31.8 (20.2-59.6) < .013†§
7.7 (0.0-17.2) 0.0 (0.0-13.2) 3.8 (0.0-33.8) NS
33.4 (11.1-61.2) 33.7 (11.1-75.4) 44.7 (11.1-75.4) NS
0.0 (0.0-22.5) 0.0 (0.0-0.0) 0.0 (0.0-6.0) NS
42.5 (20.7-52.6) 30.8 (10.2-32.1) 32.8 (7.7-52.5) NS
1 (10) 1 (10) 0 NS
6 (60) 6 (60) 8 (80) NS
3 (30) 0 1 (10) NS
2 (20) 3 (30) 2 (20) NS
4 (40) 3 (30) 3 (30) NS
5 (50) 4 (40) 6 (60) NS
5 (50) 3 (30) 5 (50) NS
Increased ABPI at 6 months, but changes less than 0.15 at 12 months (n = 21)
Baseline 6 months 12 months P value
23.8 (0.0-80.3) 23.8 (0.0-80.3) 36.8 (11.9-80.3) NS
38.1 (28.3-90.2) 18.5 (3.8-66.6) 29.4 (9.3-47) < .003†‡
19.4 (0.0-43) 9 (0.0-25.1) 11.1 (0.0-42.5) < .02†‡
44.6 (0.0-90.2) 22.6 (0.0-48.7) 22.6 (0.0-53) < .04†‡
0.0 (0.0-27.1) 0.0 (0.0-0.0) 0.0 (0.0-34) NS
27.6 (17.1-43.7) 20.3 (10.2-43.6) 24.5 (5-43.6) NS
3 (14.3) 1 (4.8) 0 NS
14 (66.7) 14 (66.7) 13 (61.9) NS
8 (38.1) 1 (4.8) 3 (14.3) < .013†‡
7 (33.3) 8 (38.1) 8 (38.1) NS
5 (23.8) 1 (4.8) 6 (28.6) NS
10 (47.6) 10 (47.6) 8 (38.1) NS
11 (52.4) 10 (47.6) 12 (57.1) NS
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sions of energy, pain, emotional reaction, sleep, social iso-
lation, and physical mobility. Swedish weights of the items
have been developed and were used in this study.15 The
total sums of the weights in each dimension are 100, indi-
cating the presence of all problems; a score of zero indi-
cates that the patient has no problem at all. Part II of the
profile consists of seven yes/no statements about the fre-
quency of daily living problems with paid employment,
housework, family relationship, social life, sex life, hob-
bies, and holidays. These are presented as a percentage of
affirmative responses. The Swedish version of the NHP
has been tested for reliability.16 The NHP scale has been
shown to have high internal consistency, with alpha values
between .86 and .73, whereas feelings of social isolation
had a lower alpha value (.58).10
The sense of coherence was measured with the Sense of
Coherence Scale (SOC), which comprises 13 statements
covering three core components of importance for coping:
comprehensibility, manageability, and meaningfulness.9
The scale has a seven-point response format, with 7 repre-
senting the strongest sense of coherence.17 The possible
scoring range is 13 to 91; the higher the score, the stronger
the sense of coherence. Previously, a Cronbach’s alpha
value of .87 was reported for the 13-item version.10
Procedure. All patients had given prior consent to par-
ticipate in the study. During their initial admission, patients
were asked by the head nurse to fill out the NHP and the
sense of coherence questionnaires by themselves, at 6 and
12 months. Demographic characteristics and history of
clinical data were obtained from the patients’ medical
records. Approval for the study was obtained in advance
from the ethics committee of the University of Lund.
Statistical analysis. The χ2 test was used as a means
of assessing differences in the hemodynamic outcome for
ABPI and walking distance for patients with claudication.
Nonparametric methods were used as a means of analyz-
ing changes in the NHP score within patients with time at
baseline and after 6 and 12 months (the Friedman two-
way analysis of variance for part I and the Cochran test for
part II). The effect size used in this study was calculated
by taking the difference between the medians before and
after intervention and dividing by the interquartile range
at baseline,18 including only those patients who at pre-
treatment had values higher than zero. Cohen19 defined
an effect size of 0.20 as small, 0.50 as moderate, and 0.80
or greater as large. A logistic regression analysis (forward
condition) was used as a means of determining factors of
importance for high quality of life 1 year after a successful
or an unsuccessful revascularization procedure (total NHP
score < 2.98, 25th percentile). Sex, age (< 70 > median
year), ABPI (< 0.93 > median score), risk factors, and
patient group (claudication/critical ischemia) were factors
found to influence the dependent variable.20 Correlation
between the total NHP score and variables was expressed
by means of the Spearman rank correlation coefficients.
Analysis was carried out with the statistical package SPSS
version 8.0 (Lund, Skane, Sweden), and a 2-tailed P value
less than .05 was considered to be statistically significant.21
RESULTS
Of the 146 patients who underwent PTA or surgical
intervention and were studied, 85 were men (58.2%) and
61 were women (41.8%), with a median age of 69 years
(q1 59 to q3 74 years) and 73 years (q1 66 to q3 80 years)
in patients with claudication and critical ischemia, respec-
tively. A total of 126 patients (86.3%) reported unilateral
symptoms, and 20 patients (13.7%) reported bilateral
symptoms. Sixty-one patients (41.8%) smoked at the time
of intervention; 30 patients (20.5%) had diabetes mellitus;
58 patients (39.7%) were treated for hypertension; 55
patients (37.7%) had a history of heart disease; 11 patients
(7.5%) had a history of cerebrovascular disease; 7 patients
(4.8%) had a history of kidney disease; 8 patients (5.5%)
had a history of chronic lung disease; and 16 patients
(11%) had a history of hyperlipemia. No significant differ-
ence in these risk factors was found between successful or
unsuccessful intervention, except for hyperlipemia and
kidney disease among patients with claudication and dia-
betes mellitus among patients with critical ischemia.
Diabetes mellitus was significantly more common among
patients with critical ischemia in the unsuccessful group (P
< .001; Table I). The median value for the sense of coher-
ence in all patients was 74 (q1 64 to q3 84). No significant
differences in the sense of coherence score at baseline, 6
months, and 12 months or between the patient groups or
between successful or unsuccessful intervention was
found. The total NHP score after a successful intervention
correlated significantly with the sense of coherence score
(r = –.40, P < .0001), age (r = .30, P < .003), patient
group (r = .29, P < .004), and ABPI (r = –.23, P < .03).
No significant relationship between risk factors and type of
intervention was found.
Clinical outcome. Of 146 patients, 97 patients
(66.4%) had a hemodynamically successful revasculariza-
tion; 87 patients had an ABPI that increased by 0.15 or
more at 6 months and remained the same or higher at 12
months, whereas 10 patients had an ABPI below 0.15 at 6
months but reached a change of 0.15 or higher at 12
months, compared with baseline. These 10 patients had
undergone a secondary revascularization during the year.
Forty-nine patients (33.6%) had an unsuccessful revascu-
larization; 28 patients had ABPI changes less than 0.15
both at 6 and 12 months, and 21 patients had an increased
ABPI at 6 months but with changes less than 0.15 at 12
months, compared with baseline. Eight patients with crit-
ical ischemia in the unsuccessful group had a major ampu-
tation. Of the 97 patients who had a successful
revascularization at the 12-month follow-up assessment,
55 patients (56.7%) had claudication only, and 42 patients
(43.3%) had critical ischemia (Table II). Patients who had
undergone a secondary revascularization had significantly
more pain (P < .02) and sleep disturbances (P < .008) at
the 12-month follow-up assessment than patients who did
not undergo a secondary revascularization. No significant
differences in the NHP score between patients who
underwent amputation and patients who had not under-
gone amputation were found. There were no significant
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differences between successful and unsuccessful interven-
tion in age, sex, leg side and level of disease, type of inter-
vention, or severity of disease. Patients with claudication
who had an increased ABPI had significantly longer walk-
ing distance (> 300 m) than patients with decreased ABPI
(P < .01; Table II). The 30 patients with improved walk-
ing distance had significant improvements in the dimen-
sion of pain (P < .0001), physical mobility (P <.0001),
energy (P < .005), emotional reactions (P < .04), and
housework (P < .0001), compared with patients with clau-
dication who did not have improved walking distance at
the 12-month follow-up assessment.
All patients. The 87 patients with varying degrees of
ischemia had a significantly lower total NHP score 1 year
after hemodynamically successful revascularization (P <
.0001), compared with baseline. All health dimensions in
part I of the NHP that were not normal at baseline were
significantly lower, indicating a higher quality of life. In
areas of daily living (part II), these patients had signifi-
cantly fewer problems in all areas, except for sex life. The
remaining 10 patients with successful revascularization
had significantly lower scores in pain (P < .01), whereas
the other dimensions were not significantly changed
(Table III). One year after hemodynamically unsuccessful
revascularization, the 28 patients had a significantly lower
score in pain (P < .0001) and the total NHP (P < .004),
whereas the other 21 patients had a significantly lower
score in pain (P < .003), the total NHP (P < .004), emo-
tional reactions (P < .02), sleep (P < .04), and family rela-
tionships (P < .01), compared with baseline (Table IV).
Subgroup analysis. One year after a hemodynamically
successful revascularization, the 55 patients with claudica-
tion had significantly lower total NHP scores (P < .0001),
compared with baseline. All health dimensions of the NHP
that were not normal at baseline were significantly lower at
12 months, compared with baseline (Fig 1). The 42
patients with critical ischemia had significant improvements
in the dimensions of pain (P < .0001), sleep (P < .0001),
and physical mobility (P < .004; Fig 2) and the total NHP
(P <.003). One year after a hemodynamically unsuccessful
revascularization, the 29 patients with claudication had sig-
nificantly lower scores in pain (P < .001) and emotional
reactions (P <.02; Fig 3) and the total NHP (P < .001),
whereas the 20 patients with critical ischemia had signifi-
cant improvements in pain (P < .0001; Fig 4) and the total
NHP (P < .01), compared with baseline.
High ABPI (OR, 5.7; CI, 1.9-17.2; P < .002),
belonging to the claudicant group (OR, 5.4; CI, 1.7-16.9;
P < .004), and a high sense of coherence (OR, 5; CI, 1.7-
15.3; P < .004) were factors significantly associated with
low total NHP score, indicating high quality of life 1 year
after a hemodynamically successful revascularization.
However, sex, age, and risk factors were not significantly
associated with high quality of life. After an unsuccessful
revascularization, sex, age, and other risk factors were also
not significantly associated with high quality of life.
One year after successful revascularization, the effect
size was regarded as large (≥ 0.80) in the dimensions of
social isolation, energy, and physical mobility (range, 0.86-
1.33), whereas after unsuccessful revascularization, the
effect size was large in the dimensions of social isolation,
emotional reactions, and sleep (range, 0.82-1.21; Table V).
DISCUSSION
This study demonstrated that a hemodynamically suc-
cessful bypass grafting or angioplasty of lower limb
Fig 1. NHP part I scores in patients with claudication (n = 55)
before , 6 months after , and 12 months after  hemody-
namically successful revascularization. *Tested by means of the
Friedman Test; **P < .05; ***P < .001.
Fig 2. NHP part I scores in patients with critical ischemia (n =
42) before , 6 months after , and 12 months after  hemody-
namically successful revascularization. *Tested by means of the
Friedman Test; **P < .01; ***P < .001.
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ischemia resulted in an immediate and lasting improve-
ment in patients’ quality of life. Despite unsuccessful
revascularization, patients had improvements, especially in
the dimensions of pain, emotional reactions, and sleep, at
the 1-year follow-up assessment. A successful revascular-
ization for patients with claudication demonstrated the
most marked quality of life benefits, including all health
dimensions that were not normal at baseline, whereas
patients with critical ischemia had improved quality of life
in the dimensions of pain, sleep, and physical mobility.
The degree to which the quality of life was improved,
however, seems to be reflected by an interplay between the
patients’ ABPI, the severity of the disease, and the
patients’ sense of coherence.
Several limitations in this investigation, which theoret-
ically could have threatened the internal validity and, thus,
the external validity, need to be taken into considera-
tion.22,23 First, patients were not randomly assigned to dif-
ferent groups. However, with a pretest/posttest design as
a means of assessing the effect of the intervention, any bias
in the selected treatment for any particular patient may be
eliminated.23 Indeed, this is supported because there were
no differences in type of intervention between successful
and unsuccessful revascularization in either patient group.
Second, progression of peripheral vascular disease and his-
tory of other comorbidity may also have influenced the
outcome. This might be reflected in the downward trend
in some of the NHP domains during the 1-year follow-up
period, for instance. However, there were no significant
differences in risk factors between patients who had under-
gone a successful or an unsuccessful intervention, with the
exception of diabetes mellitus, hyperlipemia, and kidney
disease. Third, the outcome cannot easily be taken as
resulting from one intervention. Some of the patients had
another revascularization at the same point. For instance, it
is unlikely that the improvements in ABPI in the 10
patients stem from the first intervention.
A hemodynamically successful revascularization was
one independent predictor for high quality of life in the
first year after revascularization, as shown by means of the
logistic regression analysis. This success was demonstrated
in different quality of life trends for the degree of
ischemia. After a successful bypass grafting or angioplasty
for patients with claudication, improvements were found
in most of the dimensions of the NHP, whereas patients
with critical ischemia had improvements in pain, sleep, and
physical mobility. No study has previously demonstrated
the impact of lower limb ischemia on quality of life with
time by analyzing the whole spectrum of the disease.
However, by using short form 36 (SF-36), Chetter et al24
reported improvements with a downward trend for
patients with claudication in the dimensions of physical
functioning, role physical, bodily pain, vitality, social func-
tioning, and mental health 6 months after angioplasty. In
another study,25 the same authors showed improvements
in the dimensions of physical functioning, bodily pain,
vitality, and social functioning for patients with critical
ischemia, 12 months after infrainguinal reconstruction.
The results of this study also showed improved walking
distance, followed by significant improvements in pain,
physical mobility, energy, emotional reactions, and house-
work for patients with claudication. This suggests that
hemodynamically successful revascularization improves
the quality of life in patients with varying degrees of limb
ischemia, and it also supports the validity of using quality
of life information in the outcome measurement of vascu-
Fig 3. NHP part I scores in patients with claudication (n = 29)
before , 6 months after , and 12 months after  hemody-
namically unsuccessful revascularization. *Tested by means of the
Friedman Test; P < .05; **P < .001.
Fig 4. NHP part I scores in patients with critical ischemia (n =
20) before , 6 months after , and 12 months after  hemody-
namically unsuccessful revascularization. **P < .01.
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lar surgery. It seems likely that patients with less severe
symptoms have larger improvements after revasculariza-
tion. Thus, the milder the disease, the stronger the
improvement in quality of life. It also seems likely that a
stronger sense of coherence is associated with a higher
quality of life. This interpretation coincides with
Antonovsky’s17 suggestion that sense of coherence is
related to the general health and well-being of an individ-
ual. Further, the interpretation is supported by means of
the logistic regression analysis, which showed that belong-
ing to the claudicant group and having a high sense of
coherence were other predictors for high quality of life.
Unexpectedly, the results of this study demonstrate an
immediate and lasting improvement in patients’ quality of
life, despite hemodynamically unsuccessful revasculariza-
tion, in the dimensions of pain, sleep, emotional reactions,
and family relationships in the first year after revasculariza-
tion. It is widely assumed that quality of life is improved
with successful revascularization,10,26-28 but few published
studies have described the impact on quality of life after a
failed bypass grafting. The findings in this study, however,
coincide with those reported by Duggan et al,29 who, with
a small sample, showed that functional status in patients
whose limbs were amputated did not differ from that of
patients who had successful surgery after 18 months. In
contrast, Tangelder et al30 demonstrated that amputation,
in particular after failed secondary revascularization, had a
dramatic impact on the deterioration of quality of life at
the 21-month follow-up assessment, whereas Johnsson et
al31 reported a better maintained quality of life for patients
with critical ischemia 12 months after successful treatment
than for patients after a failed revascularization. The
improvement in this study may indicate that the use of a
0.15 increase as a requirement for significant change may
be too strict and might unfairly exclude patients who ben-
efit from intervention. Also, any intervention for lower
limb ischemia is known to have a placebo effect, and it
could be argued that the quality of life benefits in patients
with unsuccessful revascularization are largely caused by
that effect. The placebo effect caused by unsuccessful
revascularization in this study is minimal, as demonstrated
by means of the only moderate improvements in the
dimension of emotional reactions, but the large improve-
ment in the dimension of pain. The results also suggested
clinical improvements for large effect size in the dimen-
sions of sleep, emotional reactions, and social isolation in
this specific group of patients. Despite the improvements
in their quality of life, the findings suggest that patients
who underwent a failed bypass grafting probably are in
greater need of support and complementary care in those
areas of the NHP that indicated a lower life quality.
As expected, hemodynamically successful revascular-
ization in lower limb ischemia reveals improvements in
most of the NHP areas. The patterns did, however, differ
with time. First, there was an immediate and lasting
improvement in the dimensions of energy, pain, emotional
reactions, sleep, physical mobility, paid employment, hob-
bies, and holidays throughout the first year. Second, in the
areas of housework, family relationships, and social life
there were significant but later improvements. Finally,
there was an immediate improvement with a downward
trend in the dimensions of energy and physical mobility.
Similar patterns have previously been reported by Chetter
et al32 for effect size (below 0.5) in the dimensions of
physical functioning, role physical, bodily pain, vitality,
and social functioning at 6 and 12 months after angio-
plasty for patients with claudication. However, Tetteroo et
al33 showed an immediate and lasting improvement in all
eight domains of the SF-36 in patients with intermittent
claudication 2 years after direct stent placement or primary
angioplasty. The results of this study confirm earlier find-
ings that show that hemodynamically successful bypass
grafting or angioplasty has an immediate and relatively
lasting impact on patients’ life quality. This result is further
supported by the large effect size (above 0.8) in the
dimensions of physical mobility, energy, and social isola-
tion in the first year after revascularization. However, the
downward trend in some areas during the first year after
bypass grafting or angioplasty may reflect the progressive
nature of the disease and comorbidity.
In conclusion, the treatment of lower limb ischemia
resulted in an immediate and relatively lasting impact on
patients’ quality of life. Patients who underwent hemody-
namically successful bypass grafting or angioplasty demon-
strated higher quality of life benefits than patients who
underwent a failed bypass grafting. Quality of life was further
determined by means of the patients’ sense of coherence.
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